Initiative 发表于 2025-3-23 10:57:09

http://reply.papertrans.cn/67/6618/661780/661780_11.png

WITH 发表于 2025-3-23 14:31:58

http://reply.papertrans.cn/67/6618/661780/661780_12.png

让你明白 发表于 2025-3-23 18:33:03

http://reply.papertrans.cn/67/6618/661780/661780_13.png

Congruous 发表于 2025-3-24 00:48:49

,The Regulation of CD1d+ and CD1d− Tumors by NKT Cells,

魔鬼在游行 发表于 2025-3-24 03:38:52

NKT Cells of Cancer Patients and How Models Can Inform Therapeutic Plans,

forestry 发表于 2025-3-24 07:22:51

Understanding the Role of Natural Killer T Cells in Hematologic Malignancies: Progress and Challeng

flex336 发表于 2025-3-24 11:23:50

http://reply.papertrans.cn/67/6618/661780/661780_17.png

amygdala 发表于 2025-3-24 17:16:30

Clinical Trials of Invariant Natural Killer T Cell-Based Immunotherapy for Cancer,

议程 发表于 2025-3-24 20:06:26

978-1-4614-2950-0Springer Science+Business Media, LLC 2012

拔出 发表于 2025-3-25 00:42:55

http://reply.papertrans.cn/67/6618/661780/661780_20.png
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Natural Killer T cells; Balancing the Regula Masaki Terabe,Jay A. Berzofsky Book 2012 Springer Science+Business Media, LLC 2012 CD1d.dendri